Collin Sutton
Otolaryngology · Baton Rouge, LANPI 1114226925
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,680 of the $9,995 with a category attached, or 66.8%. 27 manufacturers reported payments, led by Medtronic at 30.0% of the total. Among otolaryngology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $47.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Acclarent, Inc$2K
- Aerin Medical Inc.$1K
- Optinose US, Inc.$688
- Regeneron Healthcare Solutions, Inc.$612
- Sanofi$410
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$5005%
- Travel & lodging$2,71627%
- Food & beverage$6,68067%
- Education$981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 32 | $3,003 |
| Acclarent, Inc | 17 | $2,180 |
| Aerin Medical Inc. | 13 | $1,161 |
| Optinose US, Inc. | 46 | $688 |
| Regeneron Healthcare Solutions, Inc. | 21 | $612 |
| Sanofi | 19 | $410 |
| Neurent Medical Limited | 4 | $309 |
| GSK | 9 | $228 |
| Stryker | 3 | $209 |
| Integra Lifesciences Corporation | 4 | $203 |
| Alk-abello, Inc | 7 | $188 |
| Inspire Medical Systems, Inc. | 1 | $122 |
| AbbVie | 7 | $118 |
| Intersect ENT, Inc. | 2 | $85 |
| Novartis | 4 | $71 |
| Kaleo, Inc. | 4 | $65 |
| Arbor Pharmaceuticals, Inc. | 4 | $58 |
| Spirair, Inc. | 1 | $54 |
| Olympus America Inc. | 1 | $54 |
| Merck | 2 | $35 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Amgen | 1 | $20 |
| Pfizer | 1 | $19 |
| Aytu Biopharma, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUVENT$1,516
- VIVAER STYLUS$500
- RHINAER STYLUS$500
- NEUROMARK Device$152
- NEUROMARK Radiofrequency Console$152
- TruDi Nav Cable$148
- PTEYE PARATHYROID DETECTION SYSTEM$127
- Xhance$123
- Inspire$122
- DUPIXENT$122
- SCOPIS ENT$118
- NUCALA$100
How this compares
$9,995 in reported general payments places this provider in the 90th percentile of 218 otolaryngology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 268 | $8,621 |
| Epinephrine | 27 | $6,933 |
| Ipratropium Bromide | 199 | $6,150 |
| Fluocinolone Acetonide Oil | 86 | $3,430 |
| Fluticasone Propionate | 215 | $3,121 |
| Montelukast Sodium | 73 | $932 |
| Ofloxacin | 52 | $869 |
| Cefdinir | 60 | $865 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 82 | $771 |
| Mupirocin | 95 | $624 |
| Pantoprazole Sodium | 58 | $599 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $592 |
| Doxycycline Monohydrate | 57 | $541 |
| Clarithromycin | 25 | $425 |
| Prednisone | 161 | $398 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $16 | $6,93327 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 218 otolaryngology providers in Louisiana.
Other otolaryngology in Baton Rouge
- Henry BarhamBaton Rouge$32K
- James LinBaton Rouge$19K
- Andrew McWhorterBaton Rouge$12K
- Geoffrey PetersBaton Rouge$7K
- Rula MuallaBaton Rouge$6K
- Stephen HernandezBaton Rouge$6K
- Christian HallBaton Rouge$5K
- Benjamin WaltonBaton Rouge$5K
- Elliot HardyBaton Rouge$3K
- John WoodBaton Rouge$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.